about
Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastasesInhibition of stromal CXCR4 impairs development of lung metastases.Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancerCXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.Human NF-κB repressing factor acts as a stress-regulated switch for ribosomal RNA processing and nucleolar homeostasis surveillance.The proteasome inhibitor bortezomib is a potent inducer of zinc finger AN1-type domain 2a gene expression: role of heat shock factor 1 (HSF1)-heat shock factor 2 (HSF2) heterocomplexes.Nitazoxanide inhibits paramyxovirus replication by targeting the Fusion protein folding: role of glycoprotein-specific thiol oxidoreductase ERp57The second-generation thiazolide haloxanide is a potent inhibitor of avian influenza virus replication
P50
Q34994758-5E451D59-8355-4627-ABDE-ACFF21140C73Q36250217-F03F08D6-C91F-40C8-8E88-0FA269EF697FQ36293646-77DF7E45-40A1-4AB3-82D4-92DC5399BF00Q38978463-64BEEBA4-30A4-4995-A695-6A8A73EE9395Q39016162-32A6504D-5873-4CD7-B7BC-968100DF99BFQ39146191-B44A2A72-440E-4E11-80C4-334966C226DEQ56562738-E412C953-637D-4BAD-AE70-FB2CD83C1335Q59358628-3CB1B7C2-5DBE-4BF0-B381-7EAD1C1D769C
P50
description
researcher ORCID ID = 0000-0002-1140-1366
@en
name
Anna Riccio
@ast
Anna Riccio
@en
Anna Riccio
@es
Anna Riccio
@nl
type
label
Anna Riccio
@ast
Anna Riccio
@en
Anna Riccio
@es
Anna Riccio
@nl
prefLabel
Anna Riccio
@ast
Anna Riccio
@en
Anna Riccio
@es
Anna Riccio
@nl
P1153
7101820514
P21
P31
P496
0000-0002-1140-1366